Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia

References

• Jamrog L, Chemin G, Fregona V, et al. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice. Proc Natl Acad Sci U S A. 2018;115(41):10357–10362.
   PubMed Web of Science ®Google Scholar
• Nagafuji K, Miyamoto T, Eto T, et al. Prospective evaluation of minimal residual disease (MRD) monitoring to predict prognosis of adult patients with Ph-negative ALL. Eur J Haematol. 2019;103(3):164–171.
   PubMed Web of Science ®Google Scholar
• Wolach O, Amitai I, DeAngelo D J. Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia. Br J Haematol. 2017;179(5):705–723.
   PubMed Web of Science ®Google Scholar
• Jacobson S, Tedder M, Eggert J. Adult acute lymphoblastic leukemia: A genetic overview and application to clinical practice. Clin J Oncol Nurs. 2016;20(6):E147–E154.
   PubMed Web of Science ®Google Scholar
• Tu Y, Wu C. Cloning, expression and characterization of a novel human Ras-related protein that is regulated by glucocorticoid hormone. Biochim Biophys Acta. 1999;1489(2-3):452–456.
   PubMedGoogle Scholar
• Cha J Y, Kim H J, Yu J H, et al. Dexras1 mediates glucocorticoid-associated adipogenesis and diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(51):20575–20580.
   PubMed Web of Science ®Google Scholar
• Carlson G C, Lin R E, Chen Y, et al. Dexras1 a unique ras-GTPase interacts with NMDA receptor activity and provides a novel dissociation between anxiety, working memory and sensory gating. Neuroscience. 2016;322:408–415.
   PubMed Web of Science ®Google Scholar
• Joeri B, Thijs W, Johannes B, et al. Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma. Plos One. 2012;7(1):e30907.
   PubMed Web of Science ®Google Scholar
• O'Neill D, Jones D, Wade M, et al. Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy. Oncotarget. 2015;6(28):26029–26040
   PubMedGoogle Scholar
• Gao S, Jin L, Liu G, et al. Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway. Sci Rep. 2017;7(1):3202.
   PubMedGoogle Scholar
• Vaidyanathan G, Cismowski M J, Wang G, et al. The Ras-related protein AGS1/RASD1 suppresses cell growth. Oncogene. 2004;23(34):5858.
   PubMed Web of Science ®Google Scholar
• Dalgin G S, Holloway D T, Liou L S, et al. Identification and characterization of renal cell carcinoma gene markers. Cancer Inform. 2007;3(3):65.
   PubMedGoogle Scholar
• Tian J, Duan Y X, Bei C Y, et al. Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7. Horm Metab Res. 2013;45(8):593–598.
   PubMed Web of Science ®Google Scholar
• Liu X, Li Y, Chen Q, et al. Up-regulating of RASD1 and apoptosis of DU-145 human prostate cancer cells induced by Formononetin in vitro. Asian Pac J Cancer Prev. 2014;15(6):2835–2839.
   PubMedGoogle Scholar
• Lindsey J. Dexamethasone-induced Ras-related protein 1 is a potential regulatory protein in B lymphocytes. Int Immunol. 2007;19(5):583–590.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang C, Wang W, et al. High RASD1 transcript levels at diagnosis predicted poor survival in adult B-cell acute lymphoblastic leukemia patients. Leuk Res. 2019;80:26–32.
   PubMed Web of Science ®Google Scholar
• Yao Q M, Liu K Y, Gale R P, et al. Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia. BMC Cancer. 2016;16:269.
   PubMed Web of Science ®Google Scholar
• Yan C H, Jiang Q, Wang J, et al. Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remission. Biol Blood Marrow Transplant. 2014;20(9):1314–1321.
   PubMed Web of Science ®Google Scholar
• Yan C H, Liu D H, Liu K Y, et al. Risk stratificationdirected donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood. 2012;119(14):3256–3262.
   PubMed Web of Science ®Google Scholar
• Zhang J, Lu W Y, Zhang J M, et al. S100a16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia. Br J Haematol. 2019;185:836–851.
   PubMed Web of Science ®Google Scholar
• Ruan G R, Qin Y Z, Chen S S, et al. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk Res. 2006;30(9):1159–1165.
   PubMed Web of Science ®Google Scholar
• Beillard E, Pallisgaard N, van der Velden V H, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia. 2003;17(12):2474–2486.
   PubMed Web of Science ®Google Scholar
• Jabbour E, O'Brien S, Konopleva M, et al. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer. 2015;121(15):2517–2528.
   PubMed Web of Science ®Google Scholar
• Kuhnl A, Gokbuget N, Kaiser M, et al. Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. Blood. 2011;118(24):6362–6367.
   PubMed Web of Science ®Google Scholar
• Kuhnl A, Gokbuget N, Stroux A, et al. High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia. Blood. 2010;115(18):3737–3744.
   PubMed Web of Science ®Google Scholar
• Shaw E J, Haylock B, Husband D, et al. Gene expression in oligodendroglial tumors. Cell Oncol. 2011;34(4):355–367.
   Web of Science ®Google Scholar
• Wang S J, Wang P Z, Gale R P, et al. Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics. Oncotarget. 2017;8(22):35984–36000.
   PubMedGoogle Scholar
• Wong K Y, Yao Q, Yuan L Q, et al. Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma. Sci Rep. 2018;8(1):13522.
   PubMedGoogle Scholar
• de Souza Rocha Simonini P, Breiling A, Gupta N, et al. Epigenetically deregulated microRNA-375 Is involved in a positive Feedback Loop with Estrogen Receptor in breast cancer cells. Cancer Res. 2010;70(22):9175–9184.
   PubMed Web of Science ®Google Scholar
• Munagala R, Aqil F, Vadhanam MV, et al. MicroRNA ‘signature’ during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention. Cancer Lett. 2013;339(2):175–184.
   PubMed Web of Science ®Google Scholar